Interconectar estrategias de control | 14 MAY 20

Prevención y control de enfermedades no transmisibles en la respuesta COVID-19

La prevención y el control de las ENT son importantes durante esta pandemia porque las ENT son los principales factores de riesgo para los pacientes con COVID-19
Autor/a: Hans Henri P Kluge, Kremlin Wickramasinghe, Holly L Rippin, Romeu Mendes, David H Peters, Anna Kontsevaya, et al. Fuente: The Lancet DOI:https://doi.org/10.1016/S0140-6736(20)31067-9 Prevention and control of non-communicable diseases in the COVID-19 response
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1.WHO. The Thirteenth General Programme of Work, 2019–2023. World Health Organization, Geneva2019

2.Kluge H. A new vision for WHO's European Region: united action for better health. Lancet Public Health. 2020; 5: e133-e134

3.WHO Noncommunicable diseases country profiles 2018. World Health Organization, Geneva2018

4.WHO. 
Overweight. European Health Information Gateway. https://gateway.euro.who.int/en/indicators/h2020_6-overweight/visualizations/#id=17077

5.Wang B Li R Lu Z Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020; 12: 6049-6057

6.WHO. Noncommunicable diseases in emergencies. World Health Organization, Geneva2016

7.Istituto Superiore di Sanità. Characteristics of SARS-CoV-2 patients dying in Italy. Report based on available data on April 29, 2020. COVID-19. https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_29_april_2020.pdf
Date: 2020

8.Instituto de Salud Carlos III. Informe COVID-19 n° 28. 04 de mayo de 2020. Informe sobre la situación de COVID-19 en España. https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/InformesCOVID-19.aspx

9.Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Weekly. 2020; 2: 113-122

10.Richardson S Hirsch JS Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; (published online April 22.) DOI:10.1001/jama.2020.6775

11.Jordan RE Adab P Cheng KK. COVID-19-19: risk factors for severe disease and death. BMJ. 2020; 368m1198

12.Peng YD Meng K Guan HQ et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48: E004

13.Venema V. Coronavirus: should I worry about my lockdown eating?. BBC News. April 25, 2020;
https://www.bbc.com/news/stories-52329529

14.Williams B Mancia G Spiering W et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39: 3021-3104 

15.International Diabetes Federation. IDF diabetes atlas. 9th edn. International Diabetes Federation, Brussels 2019

16.Ryan DH Ravussin E Heymsfield S. COVID 19 and the patient with obesity—the editors speak out. Obesity. 2020; 28: 847

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

Contenidos relacionados
Los editores le recomiendan continuar con las siguientes lecturas: